Heparin in stroke: not for most, but the controversy lingers.
Donnan
Geoffrey A
GA
National Stroke Research Institute, Austin and Repatriation Medical Center and the University of Melbourne, Australia. donnan@austin.unimelb.edu.au
Davis
Stephen M
SM
D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy*; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D020521:Stroke / Q000188:drug therapy*
D000925:Anticoagulants; D006493:Heparin